A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
VLP Therapeutics
3B Pharmaceuticals GmbH
Bicara Therapeutics
Leap Therapeutics, Inc.
Revolution Medicines, Inc.
Carisma Therapeutics Inc
Advaxis, Inc.
Pfizer
DNAtrix, Inc.
Seagen Inc.
Fate Therapeutics
Pfizer
AbbVie
Celgene
Karyopharm Therapeutics Inc
Amgen
Sinocelltech Ltd.
Revolution Medicines, Inc.
MacroGenics
Takara Bio Inc.
Novartis
Inovio Pharmaceuticals
Traws Pharma, Inc.
Sanofi
Eli Lilly and Company
ImmunoGen, Inc.
Blaze Bioscience Australia Pty Ltd
Boehringer Ingelheim
PCI Biotech AS
Pharmacyclics LLC.